1. Home
  2. GLPG vs SKYT Comparison

GLPG vs SKYT Comparison

Compare GLPG & SKYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$27.73

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo SkyWater Technology Inc.

SKYT

SkyWater Technology Inc.

HOLD

Current Price

$36.61

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLPG
SKYT
Founded
1999
1991
Country
Belgium
United States
Employees
452
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.9B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GLPG
SKYT
Price
$27.73
$36.61
Analyst Decision
Buy
Buy
Analyst Count
2
5
Target Price
$36.50
$26.50
AVG Volume (30 Days)
263.2K
890.3K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1842.86
EPS
N/A
N/A
Revenue
N/A
$442,139,000.00
Revenue This Year
N/A
$40.16
Revenue Next Year
N/A
$4.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
29.18
52 Week Low
$26.62
$8.31
52 Week High
$37.78
$39.93

Technical Indicators

Market Signals
Indicator
GLPG
SKYT
Relative Strength Index (RSI) 36.53 52.27
Support Level N/A $26.99
Resistance Level $34.04 $39.93
Average True Range (ATR) 0.56 1.65
MACD 0.08 -0.45
Stochastic Oscillator 25.33 40.87

Price Performance

Historical Comparison
GLPG
SKYT

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, and it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

About SKYT SkyWater Technology Inc.

SkyWater Technology Inc is a U.S.-based, independent, pure-play semiconductor foundry providing foundational-node manufacturing, advanced technology development, and advanced packaging services through an integrated, multi-site operating model. It operates within the United States, with fabrication and packaging facilities in Minnesota, Texas, and Florida.l. Its segments include: Legacy SkyWater: A pure-play technology foundry that offers advanced semiconductor development and manufacturing services from its fabrication facility in Bloomington, Minnesota and advanced packaging services from its Kissimmee Florida facility; and SkyWater Texas: A high-volume manufacturer that offers manufacturing services from its fabrication facility in Austin, Texas.

Share on Social Networks: